Primera Analytical Solutions Corp.

FDA Audit

lian — Mon, 07 May 2012 19:10:12 +0000

In April, 2012 Primera had a PAI Audit by the FDA with NO 483s. Primera was previously audited by the FDA in Oct, 2008. At that time, there were also NO 483s.

ICP-MS Services Now Available

lian — Fri, 04 Nov 2011 17:21:18 +0000

Primera expands its range of services with the introduction of the Elan 9000 PerkinElmer/Sciex ICP-MS. The system provides clients with excellent detection limits, high sample throughput, and the stability required by environmental, clinical, geochemical, and general testing laboratories with moderate to heavy loads of ultratrace level samples.

Let’s meet. Lets talk. Look for Primera at the following upcoming events:

lian — Wed, 21 Sep 2011 19:38:28 +0000

Contract Pharma

New Brunswick, NJ

September 20-21, 2012

Primera’s Expansion of Bioanalytical Capacity in New Jersey

fei — Wed, 21 Sep 2011 14:13:55 +0000

Primera has recently doubled the size of its lab in Princeton, NJ. With nearly 12,000 sq ft of analytical/bioanalytical resources in New Jersey, now combined with our new 20,000 sq. ft. lab in Suzhou, China, we can handle virtually any size project.

New R&D center in Suzhou

fei — Tue, 20 Sep 2011 13:55:11 +0000

Primera Analytical Solutions Corp., a leading contract research & development organization, has announced the opening of it’s 20,000 sq. ft. R&D center in Suzhou, China. Our new R&D center in Suzhou now allows us to offer enhanced services in such areas as method development, stability and formulation at very competitive prices.

New QA Director

lian — Thu, 26 May 2011 15:54:54 +0000

Princeton, New Jersey – May 24, 2011 – Primera Analytical Solutions Corp., a leading contract research & development organization, is pleased to announce the appointment of Dr. Charles “Chip” Stewart to the position of Director, Quality Assurance. Along with an expertise in Q/A, Chip brings two decades of experience in analytical method development, testing, validation, and transfer activities according to ICH and FDA guidelines in support of pharmaceutical dosage forms, manufacturing processes, stability and extractables / leachables studies from organizations such as Fort Dodge Animal Health, Lexicon Pharmaceuticals, Firmenich and MEDA Pharmaceuticals.